Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon
Thumbnail

Gene-editing specialists raise $63M to combat coronary heart disease

Verve Therapeutics, a healthcare company focused on improving cardiovascular outcomes through gene-editing technology, has raised $63 million in Series A2 financing.

Thumbnail

Cardiologists urge heart disease patients to seek emergency care when necessary

Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.

Thumbnail

FDA approves use of ticagrelor for high-risk CAD patients

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

Thumbnail

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

Thumbnail

Heart attack care is different for male and female patients—and the inconsistency can lead to fatal results

Women are prescribed fewer drugs after a heart attack than men—and they are more likely to die afterward as a result of that disparity.

CAD deaths on the rise among young women in rural areas

Women in rural parts of the United States have experienced an increase in premature coronary artery disease (CAD) mortality, according to new findings published in the Journal of the American Heart Association.

Thumbnail

How should physicians treat STEMI patients with COVID-19? A new study aims to find out

A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

FDA approves new solution for reducing heart muscle damage after serious heart attacks

ZOLL Medical Corporation has gained FDA approval for its new SuperSaturated Oxygen (SSO2) therapy solution for treating heart muscle damage in “widowmaker” heart attacks patients.

Displaying 361 - 368 of 667

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.